The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Verrica Pharmaceuticals Inc shares valued at $2,805 were sold by Hayes Christopher G. on Mar 17 ’25. At $0.65 per share, Hayes Christopher G. sold 4,315 shares. The insider’s holdings dropped to 176,458 shares worth approximately $0.11 million following the completion of this transaction.
Also, Hayes Christopher G. sold 26,183 shares, netting a total of over 69,647 in proceeds. Following the sale of shares at $2.66 each, the insider now holds 115,303 shares.
Before that, Hayes Christopher G. had sold 9,530 shares from its account. In a trade valued at $23,444, the CHIEF LEGAL OFFICER traded Verrica Pharmaceuticals Inc shares for $2.46 each. Upon closing the transaction, the insider’s holdings decreased to 9,530 shares, worth approximately $67694.72.
As published in a research note from H.C. Wainwright on November 06, 2024, Verrica Pharmaceuticals Inc [VRCA] has been rated down from a Buy to a Neutral. Analysts at RBC Capital Mkts downgraded the stock from ‘”an Outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in early November. As of July 25, 2023, Needham has increased its “Hold” rating to a “Buy” for VRCA. Earlier on March 22, 2023, Jefferies initiated its rating. Their recommendation was “a Buy” for VRCA stock.
Analyzing VRCA Stock Performance
During the last five days, there has been a surge of approximately 54.58%. Over the course of the year, Verrica Pharmaceuticals Inc shares have dropped approximately -8.31%. Shares of the company reached a 52-week high of $0.7799 on 02/18/25 and a 52-week low of $0.3816 on 04/03/25. A 50-day SMA is recorded $0.5118, while a 200-day SMA reached $1.2958.
Support And Resistance Levels for Verrica Pharmaceuticals Inc (VRCA)
According to the 24-hour chart, there is a support level at 0.5487, which, if violated, would cause prices to drop to 0.4555. In the upper region, resistance lies at 0.7064. The next price resistance is at 0.7709. RSI (Relative Strength Index) is 67.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0957, which suggests the price will decrease in the coming days. Percent R is at 12.56%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
